Patients who suffer from MDD received ketamine (2014-15) in open study will be addressed and there depression mood will be evaluated using the rating scale that were used in the original research. In addition time of relapse and questions about their medications and drug use will be performed.
Retrospective five-year follow-up of outpatients with Major Depressive Disorder who previously received IV ketamine in 2014–15; clinical state reassessed using the same rating scales as the original study.
Assessments include time to relapse, current medications, and drug-use history; sample consists of 11 actual participants from the original protocol (study 1126).
Five-year follow-up of patients who received ketamine in 2014–15
Retrospective observational follow-up; no study dosing. Participants previously received IV ketamine in 2014–15.